Insight Clinical Trials LLC

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease8 trials
• Depression1 trial

Phase

• Phase 36 trials
• Phase 2/31 trial

Status

• Completed4 trials
• Enrolling by invitation1 trial
• Recruiting1 trial
• Suspended1 trial
• Terminated1 trial
• Withdrawn1 trial

Lead sponsor

• Cassava Sciences, Inc.2 trials
• Cognito Therapeutics, Inc.2 trials
• ACADIA Pharmaceuticals Inc.1 trial
• COMPASS Pathways1 trial
• Green Valley (Shanghai) Pharmaceuticals Co., Ltd.1 trial
• and 2 more

Running trials

• Enrolling by invitation

  Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

  NCT06245031· Cognito Therapeutics, Inc.· Source

• Recruiting

  [18F]PI-2620 Phase 3 Histopathological Study

  NCT05641688· Phase 3· Lantheus Biosciences Ltd.· Source

  Contact: Audrey Perrotin, PhD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease2 recruiting

Closed trials

• Recruiting

  ACP-204 in Adults With Alzheimer's Disease Psychosis

  NCT06159673· Phase 2/3· ACADIA Pharmaceuticals Inc.· Source

  Contact: Christine Murphy

• Completed

  Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD

  NCT05624268· Phase 3· COMPASS Pathways· Source

• Completed

  A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

  NCT05637801· Cognito Therapeutics, Inc.· Source

• Terminated

  Open-label Extension for Phase 3 Clinical Trials of Simufilam

  NCT05575076· Phase 3· Cassava Sciences, Inc.· Source

• Completed

  Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease

  NCT04994483· Phase 3· Cassava Sciences, Inc.· Source

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

  NCT04777396· Phase 3· Novo Nordisk A/S· Source